Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 29, 2015, Pages 9046-9051

  Jiang, Jianming ^a,b,c   Burgon, Patrick G ^a,d   Wakimoto, Hiroko ^a,e   Onoue, Kenji ^a   Gorham, Joshua M ^a   O'Meara, Caitlin C ^f   Fomovsky, Gregory ^f   McConnell, Bradley K ^a,g   Lee, Richard T ^f   Seidman, J G ^a   Seidman, Christine E ^a,b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF HOUSTON   (United States)

Author keywords

Cardiac dilation|cardiac hypertrophy; Cytokinesis; Hyperplasia; Myosin binding protein C

Indexed keywords

CARDIAC MYOSIN; MESSENGER RNA; MYOSIN BINDING PROTEIN C; SHORT HAIRPIN RNA; 4',6 DIAMIDINO 2 PHENYLINDOLE; AURORA KINASE; BIOLOGICAL MARKER; CALCIUM; CARRIER PROTEIN; HISTONE; INDOLE DERIVATIVE; MYOSIN-BINDING PROTEIN C; SMALL INTERFERING RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CARDIOMYOPATHY; CELL COUNT; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL HYPERPLASIA; CELL MATURATION; CELL PROLIFERATION; CELL SIZE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINESIS; G1 PHASE CELL CYCLE CHECKPOINT; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HOMOZYGOSITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; MYOFILAMENT; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RIGIDITY; SARCOMERE; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; DEPENDOPARVOVIRUS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HEART VENTRICLE; METABOLISM; PHOSPHORYLATION;

MUS;

ANIMALS; ANIMALS, NEWBORN; AURORA KINASES; BIOMARKERS; CALCIUM; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINESIS; DEPENDOVIRUS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEART VENTRICLES; HISTONES; HUMANS; INDOLES; MICE; MODELS, BIOLOGICAL; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; RNA, SMALL INTERFERING;

EID: 84937873586     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1511004112     Document Type: Article

References (48)

1. Maron BJ, et al.; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807-1816.
2. Go AS, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2014) Heart disease and stroke statistics - 2014 update: A report from the American Heart Association. Circulation 129(3):e28-e292.
3. Mann DL, Zipes DP, Libby P, Bonow RO, eds (2014) Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine (Elsevier Mosby/Saunders, Philadelphia, PA).
4. Fatkin D, Seidman CE, Seidman JG (2014) Genetics and disease of ventricular muscle. Cold Spring Harb Perspect Med 4(1):a021063.
5. McNally EM, Golbus JR, Puckelwartz MJ (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 123(1):19-26.
6. Mestroni L, Taylor MR (2013) Genetics and genetic testing of dilated cardiomyopathy: A new perspective. Discov Med 15(80):43-49.
7. Moss RL, Fitzsimons DP, Ralphe JC (2015) Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium. Circ Res 116(1):183-192.
8. Gautel M, Fürst DO, Cocco A, Schiaffino S (1998) Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: Lack of isoform transcomplementation in cardiac muscle. Circ Res 82(1):124-129.
9. Yin Z, Ren J, Guo W (2015) Sarcomeric protein isoform transitions in cardiac muscle: A journey to heart failure. Biochim Biophys Acta 1852(1):47-52.
10. Pfuhl M, Gautel M (2012) Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): Who does what, with what, and to whom? J Muscle Res Cell Motil 33(1):83-94.
11. Ackermann MA, Kontrogianni-Konstantopoulos A (2011) Myosin binding protein-C: A regulator of actomyosin interaction in striated muscle. J Biomed Biotechnol 2011: 636403.
12. Flashman E, Redwood C, Moolman-Smook J, Watkins H (2004) Cardiac myosin binding protein C: Its role in physiology and disease. Circ Res 94(10):1279-1289.
13. Sequeira V, Witjas-Paalberends ER, Kuster DW, van der Velden J (2014) Cardiac myosin-binding protein C: Hypertrophic cardiomyopathy mutations and structure-function relationships. Pflugers Archiv 466(2):201-206.
14. Kuster DW, Sadayappan S (2014) MYBPC3's alternate ending: Consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Archiv 466(2):207-213.
15. Dhandapany PS, et al. (2009) A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet 41(2):187-191.
16. McConnell BK, et al. (1999) Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104(12):1771.
17. Carrier L, et al. (2004) Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res 63(2):293-304.
18. Harris SP, et al. (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90(5):594-601.
19. Mearini G, et al. (2014) Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice. Nat Commun 5:5515.
20. Merkulov S, Chen X, Chandler MP, Stelzer JE (2012) In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null mice. Circ Heart Fail 5(5):635-644.
21. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96(1):110-118.
22. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271(5 Pt 2): H2183-H2189.
23. Snir M, et al. (2003) Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285(6):H2355-H2363.
24. Palmer BM, et al. (2004) Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. Circ Res 94(12):1615-1622.
25. Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87(2):521-544.
26. Porrello ER, et al. (2011) Transient regenerative potential of the neonatal mouse heart. Science 331(6020):1078-1080.
27. Soonpaa MH, et al. (1997) Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 99(11):2644-2654.
28. Bradford JA, Clarke ST (2011) Dual-pulse labeling using 5-ethynyl-2′-deoxyuridine (EdU) and 5-bromo-2′-deoxyuridine (BrdU) in flow cytometry. Curr Protoc Cytom Chapter 7:Unit 7.38.
29. Gerdes J, et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710-1715.
30. Poon RY (2013) Aurora B: Hooking up with cyclin-dependent kinases. Cell Cycle 12(7): 1019-1020.
31. Prasad KM, Xu Y, Yang Z, Acton ST, French BA (2011) Robust cardiomyocyte-specific gene expression following systemic injection of AAV: In vivo gene delivery follows a Poisson distribution. Gene Ther 18(1):43-52.
32. Gao G, Vandenberghe LH, Wilson JM (2005) New recombinant serotypes of AAV vectors. Curr Gene Ther 5(3):285-297.
33. Jiang J, Wakimoto H, Seidman JG, Seidman CE (2013) Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. Science 342(6154):111-114.
34. Bryant DM, et al. (2015) A systematic analysis of neonatal mouse heart regeneration after apical resection. J Mol Cell Cardiol 79:315-318.
35. Michalek AJ, et al. (2013) Phosphorylation modulates the mechanical stability of the cardiac myosin-binding protein C motif. Biophys J 104(2):442-452.
36. Palmer BM, et al. (2011) Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. Biophys J 101(7):1661-1669.
37. Previs MJ, Beck Previs S, Gulick J, Robbins J, Warshaw DM (2012) Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337(6099):1215-1218.
38. Ahuja P, Perriard E, Perriard JC, Ehler E (2004) Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes. J Cell Sci 117(Pt 15): 3295-3306.
39. Li F, Wang X, Capasso JM, Gerdes AM (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28(8):1737-1746.
40. Li F, Wang X, Gerdes AM (1997) Formation of binucleated cardiac myocytes in rat heart: II. Cytoskeletal organisation. J Mol Cell Cardiol 29(6):1553-1565.
41. Poolman RA, Li JM, Durand B, Brooks G (1999) Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res 85(2):117-127.
42. Kosaka Y, et al. (2012) 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. Mol Cell Biol 32(24):5089-5102.
43. Mahmoud AI, et al. (2013) Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497(7448):249-253.
44. Puente BN, et al. (2014) The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157(3):565-579.
45. Kulikovskaya I, McClellan GB, Levine R, Winegrad S (2007) Multiple forms of cardiac myosin-binding protein C exist and can regulate thick filament stability. J Gen Physiol 129(5):419-428.
46. Morita H, Seidman J, Seidman CE (2005) Genetic causes of human heart failure. J Clin Invest 115(3):518-526.
47. Marston S, et al. (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105(3):219-222.
48. Christodoulou DC, et al. (2014) 5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. J Clin Invest 124(3):1364-1370.